OTC advisory committee
This article was originally published in The Tan Sheet
Executive Summary
FDA requests nominations for membership on the Nonprescription Drugs Advisory Committee for terms that will begin after May 1995 in an Aug. 9 Federal Register notice. There will be three vacancies on the committee as of May 31, 1995. Committee members whose terms expire next year include: Alan Sinaiko, MD, University of Minnesota Medical School; Maria Chanco Turner, MD, National Institutes of Health; and Marcus Reidenberg, MD, New York Hospital/Cornell Medical Center
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning